Non Alcoholic Fatty Liver Clinical Trial
Official title:
Efficacy and Safety of a Probiotic Composition as Adjunct Treatment in the Comprehensive Management of Metabolism-Associated Hepatic Steatosis in Adults
Some studies have shown beneficial results with probiotics on hepatic function of subjects with fatty liver, but significant variability has been noted among probiotic formulations. This study aims at providing a comprehensive characterization of the effect of a particular probiotic formula in hepatic function of said subjects.
Some studies have shown beneficial results with probiotics on hepatic function of subjects with Non-Alcoholic Fatty Liver (NAFL) also known as Metabolism-Associated Fatty Liver (MAFL). However, meta-analyses have found significant variability among probiotic formulations. In fact, many probiotic properties are thought to be strain-specific. This study aims at providing a comprehensive characterization of a particular probiotic formula containing Lactoplantibacillus plantarum (formerly Lactobacillus plantarum) and Levilactobacillus brevis (formerly Lactobacillus brevis) in hepatic function of individuals with NAFL. The study will assess hepatic stiffness via transient elastography (Fibroscan), hepatic function via liver enzymes in serum (ALT, AST, GGT) and liver-specific inflammation via cytokeratin18 in serum, as well as some general metabolic and inflammatory markers. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03625284 -
Oral Dietary Fucoxanthin Rich Supplement for Liver Health
|
N/A | |
Completed |
NCT02923804 -
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
|
N/A | |
Completed |
NCT03222206 -
The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease
|
Phase 4 | |
Completed |
NCT03186859 -
Effects of Dietary Intervention and Surgery on NAFLD (Non-Alcoholic Fatty Liver Disease)
|
N/A | |
Completed |
NCT02030977 -
The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis
|
Phase 2/Phase 3 | |
Recruiting |
NCT06176079 -
Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease
|
||
Not yet recruiting |
NCT06138821 -
ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial
|
Phase 4 | |
Not yet recruiting |
NCT04553796 -
Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.
|
||
Not yet recruiting |
NCT03801577 -
Hepaxa Management of Non-alcoholic Fatty Liver Disease
|
N/A | |
Completed |
NCT05804422 -
Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study)
|
N/A | |
Recruiting |
NCT04625166 -
Combi-elastography Assessment of Chronic Liver Disease Multi-center Study
|
||
Recruiting |
NCT05523024 -
Effect of Probiotics or Berberine in Hepatic Steatosis Markers, Cardiometabolic and Microbiotic Profile in NAFL.
|
N/A | |
Not yet recruiting |
NCT05822622 -
Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease.
|